Answers are grounded in this paper and cite their sources.
Nanozymes are rationally designed nanomaterials that emulate the catalytic functions of natural enzymes. Owing to their tunable physicochemical properties, catalytic stability, and multifunctionality, they have emerged as powerful and adaptable platforms for cancer theranostics. They have gained prominence as advanced platforms in precision oncology, owing to their ability to efficiently produce reactive oxygen species (ROS), dynamically modulate the tumor microenvironment (TME), and orchestrate complex cascade catalytic reactions that enhance therapeutic efficacy. This review offers an in-depth analysis of the latest progress in nanozyme-enabled cancer therapy, highlighting the fundamental catalytic principles, diverse material classifications, and the strategic integration of multiple therapeutic modalities to improve treatment outcomes. It further investigates nanozymes that exhibit enzyme-like activities analogous to superoxide dismutase (SOD), catalase (CAT), peroxidase (POD), and oxidase (OXD), and their applications in cancer therapy. Finally, the review discusses key current limitations and challenges to broaden their application from oncology to diverse areas of clinical medicine.
No takes yet. Share an insight, caveat, or question.
Sarmistha Saha (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: